Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals, Inc. (AMLX) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $27.52, down 1.01% on the day, which values the company at $3.54B. Price as of 18 Nov 2026, 10:38 UTC, from Yahoo Finance.

Key facts

Share price
$27.52−1.01% today
Market value
$3.54B
200-week average
$13.9098% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Amylyx Pharmaceuticals, Inc. in more detail

AMLX trades at -23.3× next year's expected earnings. It sits 98% above its 200-week average of $13.90.

In its favour: More cash than debt. Worth checking: Weak Piotroski score.

Amylyx Pharmaceuticals, Inc. (AMLX): questions and answers

What is Amylyx Pharmaceuticals, Inc.'s market cap?

Amylyx Pharmaceuticals, Inc. is valued at $3.54B at a share price of $27.52.

Is AMLX above its 200-week moving average?

Yes. AMLX is 97.9% above its 200-week average of $13.90. Long-term investors watch that line because strong companies rarely trade below it for long.

Does AMLX pay a dividend?

Amylyx Pharmaceuticals, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Amylyx Pharmaceuticals, Inc. (AMLX) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/AMLX

Underlying data: Yahoo Finance; company filings with the SEC.